FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury.
Autophagy of mitochondria, termed mitophagy, plays an important role in cerebral ischemia-reperfusion (IR) injury, but the mechanism is not yet clear. Tissue-type plasminogen activator (tPA) is the most important thrombolytic drug in the clinical treatment of ischemic stroke and has neuroprotective effects. Here, we explored the effects of tPA on neuronal apoptosis and mitophagy following IR. We found that knocking out the tPA gene significantly aggravated brain injury and increased neuronal apoptosis and mitochondrial damage. Exposure of neurons to tPA reduced injury severity and protected mitochondria. Further studies demonstrated that this protective effect of tPA was achieved via regulation of FUNDC1-mediated mitophagy. Furthermore, we found that tPA enhanced the expression level of FUNDC1 by activating the phosphorylation of AMPK. In summary, our results confirm that tPA exerts neuroprotective effects by increasing the phosphorylation of AMPK and the expression of FUNDC1, thereby inhibiting apoptosis and improving mitochondrial function.
['Cai|Ying|Y|', 'Yang|Eryan|E|', 'Yao|Xiuhua|X|', 'Zhang|Xuebin|X|', 'Wang|Qixue|Q|', 'Wang|Yunfei|Y|', 'Liu|Ji|J|', 'Fan|Weijia|W|', 'Yi|Kaikai|K|', 'Kang|Chunsheng|C|', 'Wu|Jialing|J|']
D000818:Animals D008565:Membrane Proteins D051379:Mice D008928:Mitochondria D024101:Mitochondrial Proteins D063306:Mitophagy D009474:Neurons D015427:Reperfusion Injury D010959:Tissue Plasminogen Activator
Mitophagy tPA Ischemia-reperfusion FUNDC1 CRISPR/Cas9